JP Morgan Chase’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.1M | Sell |
62,000
-47,900
| -44% | -$24.2M | ﹤0.01% | 1798 |
|
|
2025
Q4 | $62.2M | Buy |
109,900
+53,300
| +94% | +$28.4M | ﹤0.01% | 1219 |
|
|
2025
Q3 | $25.3M | Sell |
56,600
-8,100
| -13% | -$3.89M | ﹤0.01% | 1905 |
|
|
2025
Q2 | $35.2M | Buy |
64,700
+32,600
| +102% | +$17M | ﹤0.01% | 1558 |
|
|
2025
Q1 | $15.9M | Buy |
32,100
+8,300
| +35% | +$4.59M | ﹤0.01% | 2109 |
|
|
2024
Q4 | $12.4M | Sell |
23,800
-200
| -0.8% | -$104K | ﹤0.01% | 2484 |
|
|
2024
Q3 | $11.8M | Buy |
24,000
+21,900
| +1,043% | +$10.2M | ﹤0.01% | 2468 |
|
|
2024
Q2 | $934K | Sell |
2,100
-12,400
| -86% | -$4.94M | ﹤0.01% | 4322 |
|
|
2024
Q1 | $5.79M | Sell |
14,500
-266,300
| -95% | -$101M | ﹤0.01% | 2974 |
|
|
2023
Q4 | $94.7M | Buy |
280,800
+247,200
| +736% | +$73.7M | 0.01% | 918 |
|
|
2023
Q3 | $9.82M | Buy |
33,600
+5,700
| +20% | +$1.78M | ﹤0.01% | 2254 |
|
|
2023
Q2 | $9.54M | Buy |
27,900
+6,000
| +27% | +$1.82M | ﹤0.01% | 2323 |
|
|
2023
Q1 | $5.59M | Buy |
21,900
+1,200
| +6% | +$296K | ﹤0.01% | 2724 |
|
|
2022
Q4 | $5.49M | Buy |
20,700
+4,300
| +26% | +$1.05M | ﹤0.01% | 2747 |
|
|
2022
Q3 | $3.07M | Sell |
16,400
-3,700
| -18% | -$795K | ﹤0.01% | 3136 |
|
|
2022
Q2 | $4.03M | Buy |
20,100
+4,000
| +25% | +$938K | ﹤0.01% | 2977 |
|
|
2022
Q1 | $4.86M | Buy |
16,100
+4,400
| +38% | +$1.29M | ﹤0.01% | 3033 |
|
|
2021
Q4 | $4.2M | Hold |
11,700
| – | – | ﹤0.01% | 3213 |
|
|
2021
Q3 | $3.88M | Hold |
11,700
| – | – | ﹤0.01% | 3257 |
|
|
2021
Q2 | $3.59M | Buy |
11,700
+600
| +5% | +$168K | ﹤0.01% | 3337 |
|
|
2021
Q1 | $2.73M | Sell |
11,100
-6,000
| -35% | -$1.51M | ﹤0.01% | 3472 |
|
|
2020
Q4 | $4.66M | Buy |
17,100
+11,100
| +185% | +$2.76M | ﹤0.01% | 2867 |
|
|
2020
Q3 | $1.39M | Buy |
+6,000
| New | +$1.35M | ﹤0.01% | 3465 |
|
|
2020
Q1 | – | Sell |
-69,000
| Closed | -$13.6M | – | 5503 |
|
|
2019
Q4 | $13.6M | Buy |
69,000
+63,300
| +1,111% | +$11.9M | ﹤0.01% | 1865 |
|
|
2019
Q3 | $1.03M | Hold |
5,700
| – | – | ﹤0.01% | 3817 |
|
|
2019
Q2 | $984K | Sell |
5,700
-36,000
| -86% | -$6.17M | ﹤0.01% | 3883 |
|
|
2019
Q1 | $7.93M | Sell |
41,700
-65,700
| -61% | -$11.7M | ﹤0.01% | 2246 |
|
|
2018
Q4 | $17.1M | Buy |
107,400
+56,400
| +111% | +$9.56M | ﹤0.01% | 1594 |
|
|
2018
Q3 | $9.76M | Buy |
51,000
+7,800
| +18% | +$1.39M | ﹤0.01% | 2227 |
|
|
2018
Q2 | $6.89M | Hold |
43,200
| – | – | ﹤0.01% | 2440 |
|
|
2018
Q1 | $5.95M | Hold |
43,200
| – | – | ﹤0.01% | 2430 |
|
|
2017
Q4 | $5.25M | Hold |
43,200
| – | – | ﹤0.01% | 2643 |
|
|
2017
Q3 | $4.92M | Hold |
43,200
| – | – | ﹤0.01% | 2578 |
|
|
2017
Q2 | $4.49M | Buy |
+43,200
| New | +$4.15M | ﹤0.01% | 2539 |
|
Other funds holding ISRG
VCM
VPM
JP Morgan Chase's ISRG Position: Q1 2026 in Review
JP Morgan Chase increased its Intuitive Surgical (ISRG) stake by 13% in Q1 2026, buying an estimated $260M and bringing the position to 4,593,894 shares worth $2.08B. The position accounts for 0.13% of the portfolio, ranked #155.
JP Morgan Chase first reported a position in ISRG in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.3B in Q4 2024. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.
- JP Morgan Chase held 4,593,894 shares of Intuitive Surgical worth $2.08B as of Q1 2026.
- JP Morgan Chase bought 513,014 Intuitive Surgical shares in Q1 2026, an estimated $260M.
- Intuitive Surgical made up 0.13% of JP Morgan Chase's portfolio in Q1 2026, its #155 holding.
- JP Morgan Chase first reported a position in Intuitive Surgical in Q2 2013 and has held it in 52 quarters since.
- JP Morgan Chase's Intuitive Surgical position peaked at $5.3B in Q4 2024.
- 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.